eMedicine Specialties > Dermatology > Bacterial Infections

Gonococcemia: Differential Diagnoses & Workup

Author: Robert A Schwartz, MD, MPH, Professor and Head, Dermatology, Professor of Pathology, Pediatrics, Medicine, and Preventive Medicine and Community Health, UMDNJ-New Jersey Medical School
Coauthor(s): Rajendra Kapila, MD, MBBS, Professor of Medicine, Department of Medicine, UMDNJ, New Jersey Medical School
Contributor Information and Disclosures

Updated: Jul 7, 2009

Differential Diagnoses

Acanthosis Nigricans
Reactive Arthritis
Cutaneous Manifestations of Hepatitis C
Syphilis
Lyme Disease
Meningococcemia
Psoriatic Arthritis

Other Problems to Be Considered

Other causes of arthritis and dermatitis may display a clinical picture similar to that of DGI, with some notable differences.

Reactive arthritis is a human leukocyte antigen B27 (HLA-B27)–associated condition that predominantly occurs in young men and has the clinical triad of urethritis, conjunctivitis, and arthritis. However, the distribution of the arthritis is different, occurring predominantly in the joints of the axial skeleton. The clinical picture is less acute, occurring over the course of weeks rather than days and with less severe fever. This syndrome does not respond to antibiotic therapy, and it does not have the associated dermatitis that occurs in gonococcemia.

Rheumatic fever is a rare illness in the modern era and can present with high fever, rash, arthritis, and endocarditis. This condition follows a streptococcal infection and requires long, emergent intravenous antibiotic therapy for endocarditis; it also responds well to anti-inflammatory medications.

Syphilis, an STD that commonly occurs in sexually active young adults, can also produce a rash, symptoms of arthritis, and genital lesions. However, genital involvement is usually in the form of an ulcer and not urethritis, and the rash can involve the palms and the soles. Laboratory tests, including rapid plasma reagin (RPR) titers, can aid in distinguishing syphilis from gonococcemia.

Nongonococcal septic arthritis can be caused by a variety of organisms, but it presents with an acute onset of joint swelling and pain. Culture of joint fluid commonly reveals organisms. This type of arthritis is a destructive form of arthritis that is usually monoarticular. It most frequently occurs in children and elderly persons. Immediate treatment with antibiotics is indicated.

Other conditions to consider in a patient with arthritis and skin lesions include the following: meningococcemia, hepatitis, bacterial endocarditis, SLE, tenosynovitis (eg, de Quervain disease, infectious), and other seronegative arthritides (eg, ankylosing spondylitis, Sweet syndrome, related dermal vasculitides).

Workup

Laboratory Studies

The diagnosis of DGI should be based on clinical findings and confirmed with laboratory investigations if possible.

  • CBC count: Patients with gonococcemia may have an elevated WBC count, in the range of 10,000-15,000/µL.
  • Erythrocyte sedimentation rate: The rates are usually mildly elevated, with values from 20-50 in most patients. Less than 50% of patients have erythrocyte sedimentation rates higher than 50.
  • Culture: The highest yield of N gonorrhoeae organisms is from mucosal sites, including the pharynx, the urethra, the cervix, or the rectum. Urethral and cervical cultures are typically the most revealing. Blood cultures yield positive culture results in 10-30% of patients and joint fluid in 20-30% of patients. Skin lesions yield organisms in only about 10% of patients. Immunofluorescence studies may improve the effectiveness in skin and joint fluid.
  • Polymerase and/or ligase chain reaction: These methods have a high sensitivity and a high specificity (78.6% and 96.4%, respectively). They are easily performed on urethral specimens and can even be performed on first-void urine specimens. These methods are noninvasive, rapid, sensitive, and specific, and they have facilitated the diagnosis of gonococcal infection.15 However, these methods cannot report antibiotic sensitivities; therefore, they do not eliminate the need for culture in these patients.
    • Nucleic acid amplification tests, including the polymerase chain reaction, are sensitive and specific tests, as noted above. A pseudo-outbreak of pharyngeal gonorrhea in a group of prostitutes was determined to be the result of false-positive test results due to commensal oropharyngeal Neisseria species.16
    • Specific molecular tests may produce erroneous results. In certain circumstances, it may be advisable, in consultation with a medical microbiologist, to take a sample for culture or to perform a second molecular test aimed at a different part of the bacterial genome.
    • N gonorrhoeae was identified as the causative agent in a case of culture-negative dermatitis-arthritis syndrome using real-time polymerase chain reaction.17 This technology can improve the speed and sensitivity of diagnosis and consequent management of patients with this syndrome.
  • Serologic tests: These tests include latex agglutination, enzyme-linked immunosorbent assay, immunoprecipitation, and complement fixation tests. Because of their lower sensitivity and specificity, especially in populations with a low prevalence of disease, these tests are not routinely used for diagnosis, but they can be used as adjuncts to the other laboratory tests and may help in making the diagnosis.
  • Other screenings: The US Preventive Services Task Force recommends that women at increased risk of gonorrhea also be screened for chlamydia, HIV, and syphilis.18

Other Tests

  • Because of the potential severity of pericarditis and endocarditis, a cardiologic examination, including echocardiography, is recommended, even though these conditions are rare.

Histologic Findings

Histopathologic examination reveals a vasculitislike picture with a perivascular neutrophilic infiltrate and neutrophils containing pustules in the epidermis.

Cytologic smear of cutaneous acral pustule showin...

Cytologic smear of cutaneous acral pustule showing gram-negative intracellular diplococci.

Cytologic smear of cutaneous acral pustule showin...

Cytologic smear of cutaneous acral pustule showing gram-negative intracellular diplococci.

More on Gonococcemia

Overview: Gonococcemia
Differential Diagnoses & Workup: Gonococcemia
Treatment & Medication: Gonococcemia
Follow-up: Gonococcemia
Multimedia: Gonococcemia
References

References

  1. Little JW. Gonorrhea: update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. Feb 2006;101(2):137-43. [Medline].

  2. Dawe RS, Sweeney G, Munro CS. A vesico-pustular rash and arthralgia. Clin Exp Dermatol. Jan 2001;26(1):113-4. [Medline].

  3. Belding ME, Carbone J. Gonococcemia associated with adult respiratory distress syndrome. Rev Infect Dis. Nov-Dec 1991;13(6):1105-7. [Medline].

  4. Walters DG, Goldstein RA. Adult respiratory distress syndrome and gonococcemia. Chest. Mar 1980;77(3):434-6. [Medline].

  5. Thiéry G, Tankovic J, Brun-Buisson C, Blot F. Gonococcemia associated with fatal septic shock. Clin Infect Dis. Mar 1 2001;32(5):E92-3. [Medline].

  6. Cucurull E, Espinoza LR. Gonococcal arthritis. Rheum Dis Clin North Am. May 1998;24(2):305-22. [Medline].

  7. Watring WG, Vaughn DL. Gonococcemia in pregnancy. Obstet Gynecol. Oct 1976;48(4):428-30. [Medline].

  8. Angulo JM, Espinoza LR. Gonococcal arthritis. Compr Ther. Mar 1999;25(3):155-62. [Medline].

  9. Centers for Disease Control and Prevention (CDC). Increases in gonorrhea--eight western states, 2000--2005. MMWR Morb Mortal Wkly Rep. Mar 16 2007;56(10):222-5. [Medline].

  10. Azariah S, Perkins N. Risk factors and characteristics of patients with gonorrhoea presenting to Auckland Sexual Health Service, New Zealand. N Z Med J. Apr 13 2007;120(1252):U2491. [Medline].

  11. Harth W, Linse R. Dermatological symptoms and sexual abuse: a review and case reports. J Eur Acad Dermatol Venereol. Nov 2000;14(6):489-94. [Medline].

  12. Martin IM, Foreman E, Hall V, Nesbitt A, Forster G, Ison CA. Non-cultural detection and molecular genotyping of Neisseria gonorrhoeae from a piece of clothing. J Med Microbiol. Apr 2007;56:487-90. [Medline].

  13. Ackerman AB. Hemorrhagic bullae in gonococcemia. N Engl J Med. Apr 2 1970;282(14):793-4. [Medline].

  14. Walters N, Butani L. A 16-year-old girl with recent disseminated gonococcemia now presenting with a facial rash. Ann Allergy Asthma Immunol. Feb 2005;94(2):224-7. [Medline].

  15. Muralidhar B, Rumore PM, Steinman CR. Use of the polymerase chain reaction to study arthritis due to Neisseria gonorrhoeae. Arthritis Rheum. May 1994;37(5):710-7. [Medline].

  16. Verzijl A, Berretty PJ, Erceg A, Krekels GA, Van den Brule AJ, Boel CH. [A pseudo-outbreak of pharyngeal gonorrhoea related to a false-positive PCR-result]. Ned Tijdschr Geneeskd. Mar 24 2007;151(12):689-91. [Medline].

  17. Kimmitt PT, Kirby A, Perera N, et al. Identification of Neisseria gonorrhoeae as the causative agent in a case of culture-negative dermatitis-arthritis syndrome using real-time PCR. J Travel Med. Sep-Oct 2008;15(5):369-71. [Medline].

  18. Meyers D, Wolff T, Gregory K, et al. USPSTF recommendations for STI screening. Am Fam Physician. Mar 15 2008;77(6):819-24. [Medline].

  19. Chen PL, Hsieh YH, Lee HC, et al. Suboptimal therapy and clinical management of gonorrhoea in an area with high-level antimicrobial resistance. Int J STD AIDS. Apr 2009;20(4):225-8. [Medline].

  20. Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep. Aug 4 2006;55:1-94. [Medline].

  21. Centers for Disease Control and Prevention. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep. Apr 13 2007;56(14):332-6. [Medline][Full Text].

  22. Chacko MR, Wiemann CM, Kozinetz CA, et al. New sexual partners and readiness to seek screening for chlamydia and gonorrhoea: predictors among minority young women. Sex Transm Infect. Feb 2006;82(1):75-9. [Medline].

  23. Fletcher PS, Shattock RJ. PRO-2000, an antimicrobial gel for the potential prevention of HIV infection. Curr Opin Investig Drugs. Feb 2008;9(2):189-200. [Medline].

  24. Alspaugh JA. The varied manifestations of disseminated gonococcal infection. J Tenn Med Assoc. Nov 1994;87(11):479-80. [Medline].

  25. Chodynicka B, Serwin AB, Janczylo-Jankowska M, Waugh MA. Epidemiology of syphilis and gonorrhoea in eastern Poland in the years 1988-1997. Int J STD AIDS. Oct 1999;10(10):680-4. [Medline].

  26. Harbro J. Skin manifestations of gonococcemia. Aviat Space Environ Med. May 1975;46(5):748. [Medline].

  27. Jacoby HM, Mady BJ. Acute gonococcal sepsis in an HIV-infected woman. Sex Transm Dis. Nov-Dec 1995;22(6):380-2. [Medline].

  28. Lewis DA, Pollock LM, Randell J, Wilson P, Kopelman PG. Acute gonococcal arthritis: an unusual host and pathogen combination. J Clin Pathol. Jan 1995;48(1):86-8. [Medline].

  29. Nusinow SR, Zuraw BL, Curd JG. The hereditary and acquired deficiencies of complement. Med Clin North Am. May 1985;69(3):487-504. [Medline].

  30. Nussbaum M, Scalettar H, Shenker IR. Gonococcal arthritis-dermatitis (GADS) as a complication of gonococcemia in adolescents. Clin Pediatr (Phila). Nov 1975;14(11):1037-40. [Medline].

  31. Pocock DG, Chung JY, Palm KH. Disseminated gonococcal infection vs. meningococcal infection. Am Fam Physician. Aug 1993;48(2):217-8. [Medline].

  32. Rompalo AM, Hook EW 3rd, Roberts PL, Ramsey PG, Handsfield HH, Holmes KK. The acute arthritis-dermatitis syndrome. The changing importance of Neisseria gonorrhoeae and Neisseria meningitidis. Arch Intern Med. Feb 1987;147(2):281-3. [Medline].

Further Reading

Keywords

gonococcemia, gonococcal infection, gonorrhea, arthritis-dermatitis syndrome of gonorrhea, disseminated gonococcal infection, DGI, Neisseria gonorrhoeae, N gonorrhoeae

Contributor Information and Disclosures

Author

Robert A Schwartz, MD, MPH, Professor and Head, Dermatology, Professor of Pathology, Pediatrics, Medicine, and Preventive Medicine and Community Health, UMDNJ-New Jersey Medical School
Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Physicians, and Sigma Xi
Disclosure: Nothing to disclose.

Coauthor(s)

Rajendra Kapila, MD, MBBS, Professor of Medicine, Department of Medicine, UMDNJ, New Jersey Medical School
Rajendra Kapila, MD, MBBS is a member of the following medical societies: American College of Physicians, American Medical Association, Infectious Diseases Society of America, and Infectious Diseases Society of New Jersey
Disclosure: Nothing to disclose.

Medical Editor

Gregory J Raugi, MD, PhD, Professor, Department of Internal Medicine, Division of Dermatology, University of Washington at Seattle; Chief, Dermatology Section, Primary and Specialty Care Service, Veterans Administration Medical Center of Seattle
Gregory J Raugi, MD, PhD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

Pharmacy Editor

David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Director, Dermatology Residency Training Program, Scott and White Clinic, Northside Clinic
David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Managing Editor

Jeffrey Meffert, MD, Assistant Clinical Professor of Dermatology, University of Texas Health Science Center-San Antonio
Jeffrey Meffert, MD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, Association of Military Dermatologists, and Texas Dermatological Society
Disclosure: Nothing to disclose.

CME Editor

Joel M Gelfand, MD, MSCE, Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania
Joel M Gelfand, MD, MSCE is a member of the following medical societies: Society for Investigative Dermatology
Disclosure: AMGEN Consulting fee Consulting; AMGEN Grant/research funds None; Genentech Consulting fee Consulting; Centocor Consulting fee Consulting; Centocor Grant/research funds None; Covance Consulting fee Consulting; Shire  Consulting

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.